Stay updated with breaking news from Project Nextgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced infection and spread of COVID-19.
OPK earnings call for the period ending September 30, 2023.
Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
– Company to present new data at AASLD from Phase 2 chronic hepatitis B and chronic hepatitis delta clinical trials –– Company expanding strategic focus to autoimmune diseases and immuno-oncology –– Jennifer Towne, Ph.D., appointed as Executive Vice President and Chief Scientific Officer, effective November 6, 2023...
02.11.2023 - Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ended September 30, 2023. “We continue to execute on our multiple clinical stage programs and look forward to sharing Phase ...